Emerging materials, wearables, and diagnostic advancements in therapeutic treatment of brain diseases

B Ramasubramanian, VS Reddy, V Chellappan… - Biosensors, 2022 - mdpi.com
Among the most critical health issues, brain illnesses, such as neurodegenerative conditions
and tumors, lower quality of life and have a significant economic impact. Implantable …

The classical D1 dopamine receptor antagonist SCH23390 is a functional sigma-1 receptor allosteric modulator

G Zhang, K Zhu, Q Li, Y Zhang… - Acta Pharmacologica …, 2024 - nature.com
SCH23390 is a widely used D1 dopamine receptor (D1R) antagonist that also elicits some
D1R-independent effects. We previously found that the benzazepine, SKF83959, an analog …

Prefrontal cortex mechanisms of the novel cognitive enhancer d-govadine

M Nesbit - 2023 - open.library.ubc.ca
Cognitive impairment is a debilitating feature of psychiatric disorders including
schizophrenia, mood disorders and substance use disorders. Despite cognitive impairment …